首页 › 基金 › ORBIMED ADVISORS LLC › KNSA
ORBIMED ADVISORS LLC 对 KNSA 的持仓历史
KINIKSA PHARMACEUTICALS INTL · 医疗保健
ORBIMED ADVISORS LLC 在 Q2 2026 的 13F 申报中披露持有 KNSA(KINIKSA PHARMACEUTICALS INTL)420,600 股,市值约 US$26.9M,约占其申报组合的 0.54%,在其申报持仓中市值排名第 46 位。 ORBIMED ADVISORS LLC 最近 3 个申报季度中有 3 个季度披露了 KNSA 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
ORBIMED ADVISORS LLC 对 KNSA 的持仓演变
ORBIMED ADVISORS LLC 于 Q4 2025 首次披露 KNSA 持仓:187,199 股(约 US$7.7M)。 该持仓在 Q2 2026 达到峰值 420,600 股,市值约 US$26.9M。 在 3 次申报中,ORBIMED ADVISORS LLC 1 次增持、1 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 420,600 股、市值约 US$26.9M,环比增持 240,001 股。。 持仓曾出现大幅变动:Q2 2026 增持约 133% (随后一个季度股价上涨 17%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 187.20K | $7.72M | 新进 |
| Q1 2026 | 180.60K | $8.70M | 减持 |
| Q2 2026 | 420.60K | $26.90M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 KNSA 与 13F 数据
KNSA(KINIKSA PHARMACEUTICALS INTL)属于医疗保健行业。我们追踪的基金中还有 48 只申报持有 KNSA,申报仓位最大的包括:Rubric Capital Management LP (US$255.8M), BAKER BROS. ADVISORS LP (US$181.3M), TANG CAPITAL MANAGEMENT LLC (US$144.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 KNSA 的基金
- Rubric Capital Management LP 4.00M 股 · $255.79M · Q2 2026
- BAKER BROS. ADVISORS LP 2.83M 股 · $181.28M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 2.26M 股 · $144.52M · Q2 2026
- Spruce Street Capital LP 918.07K 股 · $58.71M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 624.93K 股 · $39.96M · Q2 2026
- Penn Capital Management Company, LLC 368.11K 股 · $23.57M · Q2 2026
- Soleus Capital Management, L.P. 246.35K 股 · $15.75M · Q2 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 202.02K 股 · $15.07M · Q3 2026
- ArrowMark Colorado Holdings LLC 215.55K 股 · $13.78M · Q2 2026
- STEMPOINT CAPITAL LP 209.23K 股 · $13.38M · Q2 2026
更多关于 ORBIMED ADVISORS LLC
常见问题
How long has ORBIMED ADVISORS LLC held KNSA?
ORBIMED ADVISORS LLC has disclosed KNSA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is ORBIMED ADVISORS LLC's current position in KNSA?
As of Q2 2026, ORBIMED ADVISORS LLC holds 420.60K shares of KNSA (KINIKSA PHARMACEUTICALS INTL), valued at $26.90M, representing 0.54% of its reported portfolio and ranking #46.
Has ORBIMED ADVISORS LLC been buying or selling KNSA?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC increased its position in KNSA. The position peaked in Q2 2026 at 420.60K shares.
Which other funds hold KNSA?
Other major institutional holders of KNSA include Rubric Capital Management LP, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.